Product Information
TELMISARTAN 80 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1563 per EA under NDC 62135053730. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Jan 8, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the TELMISARTAN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/1
Manufacturer
Chartwell RX LLCNDC
62135053730
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA078710FDA Approved
1/8/2014
TE Code
AB
On Market Since
11/23/2020
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 80 MG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1563 per EA |
|---|---|
| All-time high | $0.2501 (Dec 13, 2023) |
| All-time low | $0.1345 (May 22, 2024) |
| 52-week high | $0.1634 |
| 52-week low | $0.1473 |
| Median price | $0.1566 |
| Average price | $0.1666 |
| Largest weekly change | +53.7% (Nov 22, 2023) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TELMISARTAN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Chartwell RX LLC, is $0.1563 per EA (NDC 62135053730), effective Aug 19, 2026.
How has the price of TELMISARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 13.3%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?
Since Oct 11, 2023, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.1345 (May 22, 2024) to a high of $0.2501 (Dec 13, 2023), with a median of $0.1566 per EA.
Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TELMISARTAN 80 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TELMISARTAN 80 MG TABLET?
TELMISARTAN 80 MG TABLET (NDC 62135053730) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.